Expertise in
13
conditions

George Giannakoulas

St. Kyriakidi Str 1, 
Thessaloniki, ESYE12, GR 
Expertise in
13
conditions
St. Kyriakidi Str 1, 
Thessaloniki, ESYE12, GR 

Overview

George Giannakoulas practices practicing medicine in Thessaloniki, Greece.

Giannakoulas is highly rated in 13 conditions, according to our data. Their clinical expertise encompasses Congenital Heart Disease (CHD), Pulmonary Hypertension, Hypertension, Embolectomy, and Thrombectomy.

They are actively involved in clinical research, co-authoring 297 peer reviewed articles and participating in 2 clinical trials.

Locations

St. Kyriakidi Str 1, Thessaloniki, ESYE12 54636, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study
Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study
Enrollment Status: Completed
Publish Date: November 17, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
View 1 Less Clinical Trial

297 Total Publications

Irreversible functional tricuspid regurgitation: Lessons learned after transcatheter atrial septal defect closure.
Irreversible functional tricuspid regurgitation: Lessons learned after transcatheter atrial septal defect closure.
Journal: Kardiologia polska
Published: August 17, 2026

Frequently Asked Questions about George Giannakoulas

Is George Giannakoulas a top-rated expert for Congenital Heart Disease (CHD)?

MediFind is an objective health platform that identifies experts based on real-world data. George Giannakoulas is classified as an Elite expert for Congenital Heart Disease (CHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does George Giannakoulas participate in research or clinical trials?

Yes. George Giannakoulas has published 297 articles and abstracts on conditions like Congenital Heart Disease (CHD). You can view a list of George Giannakoulas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Giannakoulas's expertise for a condition
ConditionClose
View All 57 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile